Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

Lebellec, Loïc; Bertucci, François; Tresch-Bruneel, Emmanuelle; Ray-Coquard, Isabelle; Le Cesne, Axel; Bompas, Emmanuelle; Blay, Jean-Yves; Italiano, Antoine; Mir, Olivier; Ryckewaert, Thomas; Toiron, Yves; Camoin, Luc; Goncalves, Anthony; Penel, Nicolas; Le Deley, Marie-Cécile

doi:10.1186/s12885-018-4828-1

BMC Cancer

Article metrics
Last updated: Fri, 26 Apr 2024 2:23:59 Z

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

Access & Citations

2658

Article Accesses
11

Web of Science
13

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com